Technology | December 22, 2010

Breast Biopsy Device Gains FDA Clearance

December 22, 2010 – The Mammotome molecular imaging (MI) system, which is used to conduct minimally invasive, vacuum-assisted breast biopsy (VABB) with molecular imaging guidance, has received 510(k) clearance. It is the first device of its kind to receive FDA clearance, and it is commercially available to healthcare facilities specializing in breast cancer screening and diagnosis.

The Mammotome biopsy system has been available for use with traditional imaging modalities, including stereotactic (X-ray), ultrasound and magnetic resonance imaging (MRI). The new Mammotome MI system facilitates minimally invasive breast biopsy guided by molecular imaging techniques, such as positron emission mammography (PEM) and breast-specific gamma imaging (BSGI) to localize lesions.

In traditional screening or diagnostic imaging of the breast, clinicians look at the breast for anatomical changes. With molecular imaging, however, the clinicians look for unusual metabolic activity in the breast. This is accomplished by injecting the patient with a small amount of radiopharmaceutical tracer. These radioactive substances circulate and get trapped in abnormal cells creating a unique “hot spot” which can be imaged and biopsied with the Mammotome MI system.

A procedure with the Mammotome biopsy system involves a single insertion of a needle equipped with a vacuum system into a tiny 1/4-inch incision. The system gently vacuums, cuts and removes suspicious breast tissue for analysis and diagnosis. Since the incision is so small, no stitches are required. Instead, only an adhesive bandage is needed, and most patients can return to normal activity immediately following the procedure. The outpatient procedure typically takes less than an hour, and scarring is minimal.

For more information: www.mammotome.com or www.devicormedical.com

Related Content

Patient Complexity, Subspecialization Impact List Prices for Radiologists' Services
News | Business | August 15, 2017
A new study by the Harvey L. Neiman Health Policy Institute finds that patient condition complexity and...
Upcoming radiology conferences, meetings and events.
News | August 14, 2017
ITN maintains a comprehensive listing of radiology specialty meetings on its website at ...
ACR Establishes Education Committee for Patient- and Family-Centered Care
News | Patient Engagement | August 09, 2017
Members of the new Education Committee of the American College of Radiology (ACR) Commission on Patient- and Family-...
ACR Annual Conference on Quality and Safety Offers Strategies for Radiology Practices
News | Business | August 08, 2017
The American College of Radiology (ACR) Annual Conference on Quality and Safety, scheduled for Oct. 13-14 in Boston,...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow
News | Women's Health | August 01, 2017
Fujifilm Medical Systems U.S.A., Inc. announced that The Mammography Center of Monterey, an ACR-accredited breast...
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Sponsored Content | Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
Sponsored Content | Videos | Business | July 28, 2017
Angelic McDonald, MSRS, CRA, FAHRA, regional director of imaging, Baylor Scott & White Health and the president-e
Overlay Init